VBI Vaccines Inc (VBIV)
0.5743
-0.03
(-4.19%)
USD |
NASDAQ |
Apr 26, 16:00
0.5743
0.00 (0.00%)
After-Hours: 16:49
VBI Vaccines Cash from Operations (TTM): -60.88M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -60.88M |
September 30, 2023 | -67.87M |
June 30, 2023 | -77.19M |
March 31, 2023 | -75.43M |
December 31, 2022 | -73.70M |
September 30, 2022 | -73.16M |
June 30, 2022 | -59.92M |
March 31, 2022 | -53.19M |
December 31, 2021 | -39.91M |
September 30, 2021 | -37.89M |
June 30, 2021 | -48.96M |
March 31, 2021 | -46.05M |
December 31, 2020 | -47.05M |
September 30, 2020 | -39.08M |
June 30, 2020 | -37.86M |
March 31, 2020 | -42.34M |
December 31, 2019 | -48.71M |
September 30, 2019 | -47.73M |
June 30, 2019 | -47.31M |
March 31, 2019 | -50.98M |
December 31, 2018 | -45.53M |
September 30, 2018 | -47.47M |
June 30, 2018 | -39.78M |
March 31, 2018 | -31.72M |
December 31, 2017 | -31.38M |
Date | Value |
---|---|
September 30, 2017 | -29.84M |
June 30, 2017 | -27.76M |
March 31, 2017 | -25.36M |
December 31, 2016 | -18.52M |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | -2.494M |
March 31, 2015 | -2.723M |
December 31, 2014 | -3.260M |
September 30, 2014 | -4.631M |
June 30, 2014 | -5.299M |
March 31, 2014 | -4.926M |
December 31, 2013 | -4.490M |
September 30, 2013 | -3.666M |
June 30, 2013 | -5.072M |
March 31, 2013 | -6.463M |
December 31, 2012 | -8.793M |
September 30, 2012 | -11.35M |
June 30, 2012 | -11.36M |
March 31, 2012 | -14.21M |
December 31, 2011 | -15.78M |
September 30, 2011 | -14.44M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-77.19M
Minimum
Jun 2023
-37.86M
Maximum
Jun 2020
-53.91M
Average
-48.71M
Median
Dec 2019
Cash from Operations (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | -4.131M |
Palatin Technologies Inc | -26.54M |
iBio Inc | -18.89M |
Theriva Biologics Inc | -19.00M |
Oragenics Inc | -7.291M |